How big is Cytek Biosciences, Inc.?

Jun 22 2025 06:11 PM IST
share
Share Via
As of Jun 18, Cytek Biosciences, Inc. has a market capitalization of 404.04 million, with net sales of 197.06 million and a net profit of -11.25 million over the latest four quarters. Shareholder's funds are reported at 395.74 million, and total assets amount to 502.08 million.
As of Jun 18, Cytek Biosciences, Inc. has a market capitalization of 404.04 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 197.06 million, while the sum of net profit for the same period is -11.25 million.

As of Dec 24, the shareholder's funds are reported at 395.74 million, and total assets amount to 502.08 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News